Real-world effectiveness of brentuximab vedotin versus physicians' choice chemotherapy in patients with relapsed/refractory Hodgkin lymphoma following autologous stem cell transplantation in the United Kingdom and Germany
Erin A. Zagadailov, Shelby Corman, Viktor Chirikov, Courtney Johnson, Cynthia Macahilig, Brian Seal, Mehul R. Dalal, Paul J. Broeckelmann, Tim Illidge
Research output: Contribution to journal › Article › peer-review
1Downloads
(Pure)
Fingerprint
Dive into the research topics of 'Real-world effectiveness of brentuximab vedotin versus physicians' choice chemotherapy in patients with relapsed/refractory Hodgkin lymphoma following autologous stem cell transplantation in the United Kingdom and Germany'. Together they form a unique fingerprint.